HumanOptics AG: Majority stake in HumanOptics AG to be sold to Chinese investor
HumanOptics AG / Key word(s): Miscellaneous
Majority stake in HumanOptics AG to be sold to Chinese investor
Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.
30-Aug-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Spardorfer Str. 150|
|Phone:||+49 (0)9131 - 50665-60|
|Fax:||+49 (0)9131 - 50665-93|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart|
|EQS News ID:||866581|
|End of Announcement||DGAP News Service|